Showing 116 of 116on this page. Filters & sort apply to loaded results; URL updates for sharing.116 of 116 on this page
Medicenna Provides Clinical Update and Announces First Complete ...
Medicenna Therapeutics Reports Fiscal Year 2025 Financial
MDNA Insider Trading | Medicenna Therapeutics Buys and Sells
Medicenna Announces New Clinical Data Showing Dose-Dependent ...
Medicenna Therapeutics (TSE:MDNA) Insider David Hyman Buys 10,000 ...
Medicenna Announces Filing of Final Short Form Prospectus
Medicenna Therapeutics - Crunchbase Company Profile & Funding
Medicenna Therapeutics Corp. Financial Disclosures & Filings — TradingView
Medicenna Therapeutics Corp. (MDNA:CA) Discusses New Clinical Data From ...
Medicenna Therapeutics Corp. Opens the Market
Medicenna Therapeutics Corp. - AnnualReports.com
Delighted to join Medicenna as we progress the unique and highly ...
Medicenna Therapeutics Corp. - ROE
Is Medicenna Therapeutics Closing in on a Cure for Cancer? - YouTube
Medicenna Provides Update on its Presentations at the 2024
Medicenna to showcase immunotherapy at AACR 2025 | Medicenna ...
#mdna11 | Medicenna Therapeutics Corp.
Medicenna granted five new patents for IL-2 and IL-4 Superkine ...
See the full press release here: https://lnkd.in/gAFbucwP | Medicenna ...
MDNA11 therapy shows promising results in advanced cancers | Medicenna ...
Medicenna Therapeutics opens TSX Venture Exchange, May 25, 2017 - YouTube
Medicenna Therapeutics Corp. (MDNAF) Stock Price, News, Quote & History ...
Medicenna Therapeutics (TSX:MDNA) Stock Price & Overview
Medicenna ($MDNA) entered into a Clinical Collaboration agreement w ...
Medicenna Showcases Innovative Immunotherapy Developments - Investors ...
Medicenna Intro Interview Plus Impressive Cancer Treatment Data - YouTube
Big catalyst coming up for Medicenna Therapeutics, says Research Capital
Medicenna Showcases Latest MDNA11 Monotherapy Outcomes from Phase 1/2 ...
Medicenna Therapeutics Announces Key Program Updates and
Medicenna Therapeutics has a 110 per cent upside, says Mackie Research ...
Medicenna Therapeutics completes Phase 2B study on cancer drug mdna55 ...
Medicenna corporate presentation bloom burton final 2018 | PDF
Medicenna Therapeutics (TSX:MDNA) Company Profile & Description
MDNA113: Targeted Metalloprotease Activated SuperKine | Medicenna ...
Medicenna Therapeutics Corp. (OTCMKT:MDNAF) Seasonal Chart | Equity Clock
Medicenna Therapeutics Corp. (MDNAF) Latest Stock News & Headlines ...
Medicenna Therapeutics Corp. on LinkedIn: #immunotherapy # ...
Medicenna to present MDNA11 data at ESMO Congress | Medicenna ...
Medicenna Therapeutics Corp. @ Sachs_OIF - YouTube
Medicenna to Spotlight Superkine Oncology Pipeline at Global Investor ...
Medicenna Therapeutics - YouTube
Medicenna Therapeutics Corp. on LinkedIn: #meettheteam
Medicenna Therapeutics Corp. Announces to Present Evidence of Durable ...
Medicenna Therapeutics | Medidata Solutions
Medicenna Therapeutics Corp. on LinkedIn: #immunotherapy
MDNA11 monotherapy results at AACR2024 | Medicenna Therapeutics Corp ...
Medicenna Therapeutics Corp. on LinkedIn: Medicenna today announced 1Q ...
Medicenna to Present Clinical and Preclinical Data at the 39th Annual ...
Medicenna Therapeutics (NASDAQ/TSX: MDNA) Investor Update - YouTube
Medicenna Therapeutics Corp. on LinkedIn: #tumor #mdna11 #mdna11
Medicenna - Hausarztpraxis für Allgemeinmedizin in Hamburg
Medicenna Therapeutics Corp. on LinkedIn: #jpm2025 #biotech # ...
Scientific Presentations - Medicenna Therapeutics | William Redmond
Medicenna Therapeutics Corp. on LinkedIn: We are pleased to appoint ...
MDNA11: Deep Dive on Medicenna with PRISM-11 Creator David Bakke - YouTube
Medicenna Therapeutics Corp. | LinkedIn
Medicenna Therapeutics Corp. on LinkedIn: #glioblastoma
MediCenna Ästhetische Medizin (@medicenna.aesthetik) • Instagram photos ...
🔴 Medicenna Therapeutics Corp MDNA Stock Trading Facts 🔴 - YouTube
Medicenna Therapeutics Corp. on LinkedIn: #superkines #cytokines # ...
Medicenna Therapeutics Layoffs - TheLayoff.com
Medicenna – Unlocking IL-2 and Other Cytokines’ Immunotherapy Efficacy ...
Medicenna
Medicenna Therapeutics Corp. (TSE:MDNA.TO) Seasonal Chart | Equity Clock
Medicenna Therapeutics Corp. on LinkedIn: Earlier this year, reports of ...
Medicenna Therapeutics Corp. on LinkedIn: Medicenna to Participate at ...
Medicenna reports MDNA11 expands stem-like T cells in cancer patients ...
BIG TRADING UPSIDE : MDNAF STOCK ANALYSIS | MEDICENNA THERAPEUTICS ...
Medicenna Case Study | Medidata Solutions
Medicenna Therapeutics (TSE:MDNA) Is In A Good Position To Deliver On ...
#immunotherapy #cancer #biotech #mdna11 #sabcs24 | Medicenna ...
Medicenna reports first quarter fiscal 2025 results with MDNA11 ...
Medicenna unveils positive survival results from the Phase 2b trial of ...
#immunotherapy #cancer #biotech #mdna11 #researchinnovation | Medicenna ...
Non-Opioid Pain Therapeutics Summit
MDNA-113(MDNA-113) - 药物靶点：IL-13R x IL-2R x PD-1_在研适应症：实体瘤_专利_临床_研发
Medicenna: Biotech's Breakthrough Bargain in Cancer Therapy.
Medicenna: Multiple Catalysts Ahead In 2023 (NASDAQ:MDNA) | Seeking Alpha
$MDNA announced the completion of MDNA11 dose escalation and the ...
Medicenna’s MDNA11 Shows Promising Results in Cancer Treatment ...
Excited about Medicenna's groundbreaking news: 📌 First Complete ...
Medicenna's MDNA11 Data Signals a New Front in Cancer Immunotherapy ...
Medicenna开创先例，获得FDA批准在III期注册试验设计应用混合合成对照组（Synthetic Control Arm ...
Investment Banking
#medicenna #biotech #immunotherapy #healthcareinvestment # ...
MDNA Price and Volume Analysis by 650 Day Look Back MDNA Stock Analysis ...
#immunotherapy #cancerresearch #biotech #breastcancer #mdna11 #sabcs24 ...
Mid-Sized Biopharma | Medidata Solutions - Medidata Solutions
PharmaShots Interview: Medicenna's Dr. Fahar Merchant Shares Insights ...
#immunotherapy #oncology #cancer #biotechinnovation #cancerresearch # ...
#immunology #biotech #cancer #healthcareinnovation #medicenna ...
